Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02016820 · ClinicalTrials.gov registry record · NA
Effect of Acid Suppression Medication on Pediatric Microbiome
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02016820 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 7 participants.
The verdict
NCT02016820, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The colonic microbiome is essential in health and disease, and is highly dynamic during the first several years of life. Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are widely used in children, but the effects of PPIs and H2RAs on the pediatric colonic microbiome are unknown. This study will determine whether acid suppression with these medications affects the microbiome of otherwise healthy children who are prescribed acid suppression for gastroesophageal reflux disease (GERD), and determine the duration and magnitude of microbiome changes.
Interventions
- DRUG Omeprazole (suspension)
- OTHER Lifestyle Modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02016820
The ClinicalTrials.gov registry entry for NCT02016820 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Omeprazole (suspension) is the first listed.
NCT02016820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02016820 about?
NCT02016820 is a clinical study titled "Effect of Acid Suppression Medication on Pediatric Microbiome". The colonic microbiome is essential in health and disease, and is highly dynamic during the first several years of life. Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are widely used in children, but the effects of PPIs and H2RAs on the pediatric colonic microbiome are u...
What is the current status of trial NCT02016820?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2014-11. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02016820?
The interventions under investigation include: Omeprazole (suspension) (DRUG), Lifestyle Modification (OTHER).
Who is sponsoring clinical trial NCT02016820?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.